Antihypertensive and lipid lowering treatment in 70-74 year old individuals - Predictors for treatment and blood-pressure control: A population based survey. The Hordaland Health Study (HUSK)

BMC Geriatrics

Volumn 6, Issue , 2006, Pages

  Brekke, Mette ^a   Hunskaar, Steinar ^b   Straand, Jørund ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ELDERLY CARE; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; IMMOBILIZATION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MEDICAL EXAMINATION; OBESITY; QUESTIONNAIRE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SMOKING CESSATION; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; DRUG EFFECTS; EPIDEMIOLOGY; MORTALITY; NORWAY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; RISK FACTOR;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; HEALTH SURVEYS; HUMANS; HYPOLIPIDEMIC AGENTS; LIFE STYLE; MALE; NORWAY; OVERWEIGHT; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 33750552319     PISSN: 14712318     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/1471-2318-6-16     Document Type: Review

References (31)

1. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, al : European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003, 24:1601-1610.
2. Chobanian AV, Bakris GL, Black HR: The seventh report of the Joint National Committee on prevention, detection , evaluation, and treatment of high blood pressure: the JNC7 report. JAMA 2003, 289:2560-2572.
3. Organization WH: Atrerial hypertension andischemic heart disease. Preventive aspects. WHO Techn Rep Ser 1962; No 231 1962.
4. Hetlevik I: The role of clinical guidelines in cardiovascular risk intervention in general practice. Trondheim: Bjaerum, NTNU; 1999.
5. Getz L, Kirkengen AL, Hetlevik I, Romundstad S, Sigurdsson JA: Ethical dilemmas arising from implementation of the European guidelines on cardiovascular disease prevention in clinical practice. Scand J Prim Health Care 2004, 22:202-208.
6. Tonstad S, Rosvold EO, Furu K, Skurtveit S: Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001. J Intern Med 2004, 255:494-502.
7. Tonstad S, Furu K, Rosvold EO, Skurtveit S: Determinants of control of high blood pressure. The Oslo health study 2000-2001. Blood Pressure 2004, 13:1-7.
8. Bergen U: Helseundersøkelsen i Hordaland. [http://www.uib.no/isf/ husk].
9. Organization WH: Guidelines for ATC classification and DDD assignment. Oslo, Norway, WHO Collaborating Centre for Drug Statistics Methodology.; 1998.
10. Lamberts H: International Classification of Primary Health Care. Oxford, Oxford Medical Publications. Oxford University Press; 1983.
11. Soegaard AJ, Selmer R, Bjertness E, Thelle D: The Oslo Health Study: The impact of self-selection in a large, population based survey. International Journal for Equity in Health 2004, 3:1-28.
12. West SL, Strom BL, Poole C: Validity of Pharmacoepidemiology Drug and Diagnosis Data. In Pharmacoepidemiology Edited by: Strom B. New York, John Wiley & Sons; 2000.
13. Cartwright A, Smith C: Elderly people, their medicines, and their doctors. London and New York, Routledge; 1988.
14. Straand , Rokstad KS: Elderly patients in general practice: diagnoses, drugs, and inappropriate prescriptions. Fam Pract 1999, 16:380-388.
15. Chapman RH, Brenner JS, Petrilla AA, Tierce JC, SR C, battleman DS, Schwartz JS: Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med 2005, 165:1147-1152.
16. Chen YF, Dewey ME, Avery AJ: Self-reported medication use for older people in England and Wales. Journal of Clinical Pharmacy and Therapeutica 2001, 26:129-140.
17. Barat I, Andreasen F, Damsgaard EMS: The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 2000, 56:501-509.
18. Lernfelt B, Samuelsson O, Skoog I, Landahl S: Changes in drug treatment in th elderly between 1971 and 2000. Eur J Clin Pharmacol 2003, 59:637-644.
19. Manufacturers NAP: Facts and Figures, medicines and healthcare. Oslo, Norwegian Association of Pharmaceutical Manufacturers; 2002.
20. Brekke M, Hunskaar S, Straand J: Does an unhealth lifestyle predict drug use in the elderly? - A point prevalence study among 70-74 year olds living in the community. submitted 2005.
21. Thomas HF, Sweetnam PM, Janchawee B, Luscombe DK: Polypharmacy among older men in South Wales. Eur J Clin Pharmacol 1999, 55:411-415.
22. Svanquist K, Eggen AL: Treatment with antihypertensive drugs - who do we treat and how are they treated? (Norwegian). Norsk Epidemiologi 2003, 13:45.
23. Marmot MG, Smith GD, Stansfeld S, Patel C, North F, Head J, White I, Brunner E, Feeney A: Health inequalities among British civil servants: the Whitehall II study. Lancet 1991, 337:1387-1393.
24. Chrischilles EA, DJ F, RB W, JH L, TP S, JT H, RJ G, AM O, JM G: Use of medication by persons 65 and over: Data from the established populations for epidemiologic studies of the elderly. Journal of Gerontology 1992, 47:137-144.
25. Colsher PL, Wallace RB, Pomrehn PR: Demographic and health characteristics of elderly smokers: results from the Established Populations for Epidemiologic Studies of the Elderly. Am J Prev Med 1990, 6:61-70.
26. Doll R, Peto R, J B: Mortality in relation to smoking: 50 years' observations on male Britsh doctors. BMJ 2004, 328:1519-1528.
27. Doll R: One for the heart. BMJ 1997, 315:1664-1668.
28. Rochon PA, Gurwitz JH: Prescribing for seniors: Neither too much nor too little. JAMA 1999, 282:113-115.
29. Gurwitz JH: Polypharmacy. A new paradigm for quality drug therapy in the elderly? (Editorial). Arch Intern Med 2004, 164:1957-1959.
30. Dornbrook-Lavender KA: Secondary prevention of coronary heart disease in the elderly. The Annals of Pharmacotherapy 2003, 37:1867-1876.
31. Borzecki AM, Wong AT, Hickey EC, Ash AS, Berlowitz DR: Hypertension control. How well are we doing? Arch Int Med 2003, 163:2705-2711.